Follow
Anurag Sood
Anurag Sood
Zoetis
Verified email at zoetis.com
Title
Cited by
Cited by
Year
Peroral Route:  An Opportunity for Protein and Peptide Drug Delivery
A Sood, R Panchagnula
Chemical Reviews 101 (11), 3275-3304, 2001
2602001
Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research
MVS Varma, S Khandavilli, Y Ashokraj, A Jain, A Dhanikula, A Sood, ...
Current drug metabolism 5 (5), 375-388, 2004
1132004
Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method
R Panchagnula, A Sood, N Sharda, K Kaur, CL Kaul
Journal of pharmaceutical and biomedical analysis 18 (6), 1013-1020, 1999
1101999
Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index
A Sood, R Panchagnula
International journal of pharmaceutics 261 (1-2), 27-41, 2003
932003
Drug release evaluation of diltiazem CR preparations
A Sood, R Panchagnula
International Journal of Pharmaceutics 175 (1), 95-107, 1998
901998
Role of dissolution studies in controlled release drug delivery systems
A Sood, R Panchagnula
STP pharma sciences 9 (2), 157-168, 1999
541999
Circadian rhythm and drug delivery design
SP Vyas, A Sood, P Venugopalan, N Mysore
Die Pharmazie 52 (11), 815-820, 1997
411997
Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
SP Vyas, P Venugopalan, A Sood, N Mysore
Die Pharmazie 52 (5), 339-345, 1997
201997
Controlled-Release Dosage Forms for Diltiazem Hydrochloride
A Sood, Y Ashokraj, R Panchagnula
Pharmaceutical Technology, 2004
172004
Analysis of frusemide and spironolactone mixtures using first‐derivative spectrophotometry
R PANCHAGNULA, K KAUR, A SOOD, I SINGH
Pharmacy and Pharmacology Communications 3 (8), 425-429, 1997
131997
A multiunit matrix-based particulate system for controlled delivery of nifedipine
A SOOD, Y ASHOKRAJ, R PANCHAGNULA
Pharmaceutical technology (2003) 28 (11), 84-102, 2004
122004
tablet dosage form comprising cetirizine and pseudoephedrine
BK Padhi, A Sood, AK Rampal
US Patent App. 12/303,609, 2010
102010
Controlled ocular drug delivery and vesicular systems: an overview
N Mysore, A Sood, P Venugopalan, SP Vyas
Indian drugs 33 (9), 431-442, 1996
81996
Analysis of rifampicin and its main metabolite in presence of pyrazinamide and isoniazid in plasma and urine samples by HPLC method
R Panchagnula, A Sood, N Sharda, KJ Kaur, CL Kaul
J Pharm Biomed Anal 18, 1505-1022, 1999
71999
Synthetic peptides: a modern approach to vaccination.
A Sood, P Venugopalan, N Mysore, SP Vyas
Indian journal of experimental biology 36 (9), 849-861, 1998
61998
Liposomes in cosmetics and skin care
A Sood, P Venugopalan, N Venkatesan, SP Vyas
Indian drugs 33 (2), 43-49, 1996
51996
Development and in-vitro evaluation of matrix based CR pellets for Diltiazem HC*** 1 using extrusion and spheronization
A Sood, R Panchagnula
Journal of Pharmacy and Pharmacology 50 (Supplement_9), 181-181, 1998
21998
Drug release evaluation of Diltiazem HCl CR preparations
A Sood, R Panchagnula
Journal of Pharmacy and Pharmacology 50 (Supplement_9), 179-179, 1998
11998
Self Emulsifying Drug Delivery Systems: Potential in Improved Drug Delivery
A Sood, P Venugopalan, N Mysore, SP Vyas
Indian drugs 33 (11), 537-542, 1996
11996
DRUG DELIVERY/FORMULATION-A Multiunit Matrix-Based Particulate System for Controlled Delivery of Nifedipine
A Sood, Y Ashokraj, R Panchagnula
Pharmaceutical Technology 28 (11), 84-103, 2004
2004
The system can't perform the operation now. Try again later.
Articles 1–20